NDC 72934-4069

DEXAMETHASONE SODIUM PHOSPHATE 0.1% / FINASTERIDE 0.1% / MINOXIDIL 5%

Dexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5%

DEXAMETHASONE SODIUM PHOSPHATE 0.1% / FINASTERIDE 0.1% / MINOXIDIL 5% is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Minoxidil; Finasteride; Dexamethasone Sodium Phosphate.

Product ID72934-4069_8861bc75-99f4-44f2-e053-2a95a90a1fe0
NDC72934-4069
Product TypeHuman Prescription Drug
Proprietary NameDEXAMETHASONE SODIUM PHOSPHATE 0.1% / FINASTERIDE 0.1% / MINOXIDIL 5%
Generic NameDexamethasone Sodium Phosphate 0.1% / Finasteride 0.1% / Minoxidil 5%
Dosage FormSolution
Route of AdministrationTOPICAL
Marketing Start Date2019-05-09
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameMINOXIDIL; FINASTERIDE; DEXAMETHASONE SODIUM PHOSPHATE
Active Ingredient Strength5 g/100g; g/100g; g/100g
Pharm ClassesArteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC],5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-4069-8

60 g in 1 BOTTLE, GLASS (72934-4069-8)
Marketing Start Date2019-05-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-4069-8 [72934406908]

DEXAMETHASONE SODIUM PHOSPHATE 0.1% / FINASTERIDE 0.1% / MINOXIDIL 5% SOLUTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-09

Drug Details

Active Ingredients

IngredientStrength
MINOXIDIL5 g/100g

Pharmacological Class

  • Arteriolar Vasodilation [PE]
  • Arteriolar Vasodilator [EPC]
  • 5-alpha Reductase Inhibitor [EPC]
  • 5-alpha Reductase Inhibitors [MoA]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Arteriolar Vasodilation [PE]
  • Arteriolar Vasodilator [EPC]
  • 5-alpha Reductase Inhibitor [EPC]
  • 5-alpha Reductase Inhibitors [MoA]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.